Vafarma, UAB - financials and debts

Company age: 2 y. 8 mo.

Update

Vafarma - Company finances

EUR
2024
From: 2024-01-02
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 76,295 37,206
Profit before tax 90,268 16,140
Net profit 90,268 15,158
Equity 92,768 72,925
Liabilities 630 2,669
Non-current assets 5,372 4,841
Current assets 88,026 70,753
Total assets 93,398 75,594
Taxes paid
STI taxes 13,776 12,913
Financial indicators
Revenue change y/y - -51.2%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 96.6% 20.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 97.3% 20.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 118.3% 40.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 118.3% 43.4%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 76,295 18,603

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Vafarma - Social security debts

From To Debt, €
2026-08-26 2026-09-02 0.36
2026-08-23 2026-08-23 0.36
2026-08-19 2026-08-19 0.36
2026-07-23 2026-08-06 0.36
2026-06-16 2026-06-21 263.74

Vafarma - VMI tax arrears

From To Overdue, €
2026-01-01 2026-01-22 0.14
2025-11-28 2025-12-23 0.14
2025-07-28 2025-08-24 0.24
2025-06-28 2025-07-24 0.24

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Vafarma, UAB (code 306651259) is a Private Limited Liability Company engaged in business and other management consultancy activities. In 2025, revenue reached €37.2K, down 51.2% from €76.3K in 2024. Net profit was €15.2K in 2025, compared with €90.3K in 2024, indicating a clear decline in earnings, although the company remained profitable. The 2025 net margin was 40.7%. Over the two-year period, the company shows a lower revenue base and a normalization of profit after an exceptionally strong 2024 result. At the end of 2025, total assets stood at €75.6K, equity at €72.9K and liabilities at €2.7K, which points to a very conservative balance sheet. The equity ratio was 96.5% and debt-to-equity 0.04. ROE was 20.8% and ROA 20.1%, while asset turnover was 0.49x. Revenue per employee was €18.6K and profit per employee €7.6K.